Asia Sejahtera Mina Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asia Sejahtera Mina Tbk trades at Rp1,605 (market cap 1.29T, 1.47M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 31.1K 24h volume). The key difference: Asia Sejahtera Mina Tbk is far larger — about 7.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Asia Sejahtera Mina Tbk is more actively traded (1.47M versus 31.1K). Which is the better fit depends on your goals.
| AGAR | OBAT | |
|---|---|---|
Market Cap | 1.29T | 164.65B |
Volume | 1.47M | 31.1K |
Lot | 14.75K | 311 |
Turnover | 2.34B | 7.51M |
Average Price | 1,588.75 | 241.62 |
Value | 2.34B | 7.51M |
Indicative Equilibrium Price | 1,445 | 238 |
Indicative Equilibrium Volume | 253 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asia Sejahtera Mina Tbk (the Company) was established based on Notarial Deed No. 12 dated August 27, 2008 of Amelia Kasih, S.H., MKn. The parent company of the Company is PT Sinar Terang Asia Raya and the main parent entity is PT Indo Kreasi Pratama, both of which were established in Indonesia.
Read more on AGAR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →